Investorideas.com newswire, breaking biotechnology and pharma news

Thursday, November 9, 2017

Investorideas.com - #Biopharma Stock News: Sage Therapeutics (NASDAQ: $SAGE) Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression

Investorideas.com - #Biopharma Stock News: Sage Therapeutics (NASDAQ: $SAGE) Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression

No comments:

Post a Comment